Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency.
Autoinflammation
Interferon stimulated genes (ISGs)
Low-density granulocytes
NEMO deficiency
Neutrophil activation related genes
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
05
04
2021
accepted:
20
10
2021
pubmed:
15
1
2022
medline:
21
4
2022
entrez:
14
1
2022
Statut:
ppublish
Résumé
NF-κB essential modulator (NEMO, IKK-γ) deficiency is a rare combined immunodeficiency caused by mutations in the IKBKG gene. Conventionally, patients are afflicted with life threatening recurrent microbial infections. Paradoxically, the spectrum of clinical manifestations includes severe inflammatory disorders. The mechanisms leading to autoinflammation in NEMO deficiency are currently unknown. Herein, we sought to investigate the underlying mechanisms of clinical autoinflammatory manifestations in a 12-years old male NEMO deficiency (EDA-ID, OMIM #300,291) patient by comparing the immune profile of the patient before and after hematopoietic stem cell transplantation (HSCT). Response to NF-kB activators were measured by cytokine ELISA. Neutrophil and low-density granulocyte (LDG) populations were analyzed by flow cytometry. Peripheral blood mononuclear cells (PBMC) transcriptome before and after HSCT and transcriptome of sorted normal-density neutrophils and LDGs were determined using the NanoString nCounter gene expression panels. ISG15 expression and protein ISGylation was based on Immunoblotting. Consistent with the immune deficiency, PBMCs of the patient were unresponsive to toll-like and T cell receptor-activators. Paradoxically, LDGs comprised 35% of patient PBMCs and elevated expression of genes such as MMP9, LTF, and LCN2 in the granulocytic lineage, high levels of IP-10 in the patient's plasma, spontaneous ISG15 expression and protein ISGylation indicative of a spontaneous type I interferon (IFN) signature were observed, all of which normalized after HSCT. Collectively, our results suggest that type I IFN signature observed in the patient, dysregulated LDGs and spontaneously activated neutrophils, potentially contribute to tissue damage in NEMO deficiency.
Identifiants
pubmed: 35028801
doi: 10.1007/s10875-021-01176-3
pii: 10.1007/s10875-021-01176-3
doi:
Substances chimiques
IKBKG protein, human
0
I-kappa B Kinase
EC 2.7.11.10
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
582-596Subventions
Organisme : Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
ID : 318S202
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Karin M, Delhase M. The IκB kinase (IKK) and NF-κB: Key elements of proinflammatory signalling. Semin Immunol. 2000;12:85–98.
pubmed: 10723801
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:e17023.
Schmitz ML, Krappmann D. Controlling NF-κB activation in T cells by costimulatory receptors. Cell Death Differ. 2006;13:834–42.
pubmed: 16410801
Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: Balancing life and death - A new approach to cancer therapy. J Clin Invest. 2005;115:2625–32.
pubmed: 16200195
pmcid: 1236696
Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol J Clin Immunol. 2020;40:66–81.
pubmed: 32048120
Döffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat Genet. 2001;27:277–85.
pubmed: 11242109
Smahl A, Courtols G, Vabres P, Yamaoka S, Heuertz S, Munnich A, et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. Nature. 2000;405:466–72.
Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555–62.
pubmed: 11047757
pmcid: 1287930
Braue J, Murugesan V, Holland S, Patel N, Naik E, Leiding J, et al. NF-κB essential modulator deficiency leading to disseminated cutaneous atypical mycobacteria. Mediterr J Hematol Infect Dis. 2015;7:e2015010.
pubmed: 25574369
pmcid: 4283928
Huppmann AR, Leiding JW, Hsu AP, Raffeld M, Uzel G, Pittaluga S, et al. Pathologic findings in NEMO deficiency: A surgical and autopsy survey. Pediatr Dev Pathol. 2015;18:387–400.
pubmed: 26230867
Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation. J Allergy Clin Immunol. 2004;113:725–33.
pubmed: 15100680
Ramírez-Alejo N, Alcántara-Montiel JC, Yamazaki-Nakashimada M, Duran-McKinster C, Valenzuela-León P, Rivas-Larrauri F, et al. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura. Clin Immunol. 2015;160:163–71.
pubmed: 26117626
Takada H, Nomura A, Ishimura M, Ichiyama M, Ohga S, Hara T. NEMO mutation as a cause of familial occurrence of Behçet’s disease in female patients. Clin Genet. 2010;78:575–9.
pubmed: 20412081
Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, Heyman MB, et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol. 2009;132:124–31.
pubmed: 19375390
pmcid: 2800791
Nenci A, Becker C, Wullaert A, Gareus R, Van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557–61.
pubmed: 17361131
Fusco F, Pescatore A, Conte MI, Mirabelli P, Paciolla M, Esposito E, et al. EDA-ID and IP, Two Faces of the Same Coin: How the Same IKBKG / NEMO Mutation Affecting the NF-B Pathway Can Cause Immunodeficiency and/or Inflammation. Int Rev Immunol. 2015;34:445–59.
pubmed: 26269396
Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, et al. A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs. J Immunol. 2010;184:3284–97.
pubmed: 20164424
Mistry P, Nakabo S, O’Neil L, Goel RR, Jiang K, Carmona-Rivera C, et al. Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2019;116:25222–8.
pubmed: 31754025
pmcid: 6911190
Rahman S, Sagar D, Hanna RN, Lightfoot YL, Mistry P, Smith CK, et al. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Ann Rheum Dis. 2019;78:957–66.
pubmed: 31040119
Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, et al. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 2013;72:1639–45.
pubmed: 23117242
Lee-Kirsch MA. The Type i Interferonopathies. Annu Rev Med. 2017;68:297–315.
pubmed: 27813875
Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. J Allergy Clin Immunol Pract. 2019;7:2790-2800.e15.
pubmed: 31238161
pmcid: 6842687
Ogulur I, Kiykim A, Baser D, Karakoc-Aydiner E, Ozen A, Baris S. Lymphocyte Subset Abnormalities in Pediatric-Onset Common Variable Immunodeficiency. Int Arch Allergy Immunol. 2020;181:228–37.
pubmed: 31901904
Yucel E, Karakus IS, Krolo A, Kiykim A, Heredia RJ, Tamay Z, et al. Novel Frameshift Autosomal Recessive Loss-of-Function Mutation in SMARCD2 Encoding a Chromatin Remodeling Factor Mediates Granulopoiesis. J Clin Immunol. 2021;41:59–65.
pubmed: 33025377
Kayaoglu B, Kasap N, Yilmaz NS, Charbonnier LM, Geckin B, Akcay A, et al. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation. J Clin Immunol. 2021;769–779.
Klemann C, Pannicke U, Morris-Rosendahl DJ, Vlantis K, Rizzi M, Uhlig H, et al. Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency. Clin Immunol. 2016;164:52–6.
pubmed: 26812624
pmcid: 6101191
Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, et al. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans. PLoS One. 2015;10:e0121546.
pubmed: 25799053
pmcid: 4370675
Wither JE, Prokopec SD, Noamani B, Chang NH, Bonilla D, Touma Z, et al. Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms. PLoS One. 2018;13:e0196117.
pubmed: 29742110
pmcid: 5942792
Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 1986;29:1334–42.
pubmed: 2430586
Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197:711–23.
pubmed: 12642603
pmcid: 2193846
Kegerreis BJ, Catalina MD, Geraci NS, Bachali P, Lipsky PE, Grammer AC. Genomic Identification of Low-Density Granulocytes and Analysis of Their Role in the Pathogenesis of Systemic Lupus Erythematosus. J Immunol. 2019;202:3309–17.
pubmed: 31019061
Kruzel ML, Zimecki M, Actor JK. Lactoferrin in a context of inflammation-induced pathology. Front Immunol. 2017;8:1438.
pubmed: 29163511
pmcid: 5681489
Holzinger D, Foell D, Kessel C. The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases. Mol Cell Pediatr. 2018;5:7.
pubmed: 30255357
pmcid: 6156694
Pandey R, Zhou M, Islam S, Chen B, Barker NK, Langlais P, et al. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target. Sci Rep. 2019;9:18347.
pubmed: 31797958
pmcid: 6893022
Skubitz KM, Skubitz APN. Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. J Transl Med. 2008;6:78.
pubmed: 19077207
pmcid: 2628881
Tardif MR, Chapeton-Montes JA, Posvandzic A, Pagé N, Gilbert C, Tessier PA. Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux. J Immunol Res. 2015;2015:296149.
pubmed: 27057553
pmcid: 4736198
Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms The production by leukocytes of superoxide a potential bactericidal agent. J Clin Invest. 1973;52:741–4.
pubmed: 4346473
pmcid: 302313
Hidalgo A, Chilvers ER, Summers C, Koenderman L. The Neutrophil Life Cycle. Trends Immunol. 2019;40:584–97.
pubmed: 31153737
Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev. 2010;62:726–59.
pubmed: 21079042
pmcid: 2993259
Gul E, Sayar EH, Gungor B, Eroglu FK, Surucu N, Keles S, et al. Type I IFN–related NETosis in ataxia telangiectasia and Artemis deficiency. J Allergy Clin Immunol. 2018;142:246–57.
pubmed: 29155101
Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem. 1992;267:7806–13.
pubmed: 1373138
Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A. 2007;104:1371–6.
pubmed: 17227866
pmcid: 1783119
Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16:423–39.
pubmed: 29769653
pmcid: 7097117
Liu M, Guo S, Hibbert JM, Jain V, Singh N, Wilson NO, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22:121–30.
pubmed: 21802343
pmcid: 3203691
Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ, et al. Hypomorphic NEMO mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122:1169.
pubmed: 18851874
pmcid: 2710968
Barczewski AH, Ragusa MJ, Mierke DF, Pellegrini M. The IKK-binding domain of NEMO is an irregular coiled coil with a dynamic binding interface. Sci Rep. 2019;9:2950.
pubmed: 30814588
pmcid: 6393490
Maubach G, Schmädicke AC, Naumann M. NEMO Links Nuclear Factor-κB to Human Diseases. Trends Mol Med. 2017;23:1138–55.
pubmed: 29128367
Li XH, Fang X, Gaynor RB. Role of IKKγ/NEMO in Assembly of the IκB Kinase Complex. J Biol Chem. 2001;276:4494–500.
pubmed: 11080499
Rushe M, Silvian L, Bixler S, Chen LL, Cheung A, Bowes S, et al. Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site. Structure. 2008;16:798–808.
pubmed: 18462684
Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 1998;395:297–300.
pubmed: 9751060
Wu C-J, Conze DB, Li T, Srinivasula SM, Ashwell JD. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat Cell Biol. 2006;8:398–406.
pubmed: 16547522
de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020;130:1669–82.
pubmed: 31874111
pmcid: 7108905
Nelson RT, Boyd J, Gladue RP, Paradis T, Thomas R, Cunningham AC, et al. Genomic Organization of the CC Chemokine MIP-3α/CCL20/LARC/EXODUS/SCYA20, Showing Gene Structure, Splice Variants, and Chromosome Localization. Genomics. 2001;73:28–37.
pubmed: 11352563
Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, et al. Molecular Cloning of a Novel Human CC Chemokine Liver and Activation-regulated Chemokine (LARC) Expressed in Liver: Chemotactic Activity for Lymphocytes and Gene Localization on chromosome 2. J Biol Chem. 1997;272:5846–53.
pubmed: 9038201
Croft M. Costimulation of T cells by OX40, 4–1BB, and CD27. Cytokine Growth Factor Rev. 2003;14:265–73.
pubmed: 12787564
Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M. Liu Z gang The Distinct Roles of TRAF2 and RIP in IKK Activation by TNF-R1: TRAF2 Recruits IKK to TNF-R1 while RIP Mediates IKK Activation. Immunity. 2000;12:419–29.
pubmed: 10795740
Masson PL, Heremans JF, Schonne E. Lactoferrin, an Iron-Binding Protein in Neutrophilic Leukocytes. J Exp Med. 1969;130:643–58.
pubmed: 4979954
pmcid: 2138704
Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917–21.
pubmed: 15531878
Starkey PM, Barrett AJ. Human cathepsin G. Catalytic and immunological properties Biochem J. 1976;155:273.
pubmed: 7245
Brignone C, Munoz O, Batoz M, Rouquette-Jazdanian A, Cousin J-L. Proteases produced by activated neutrophils release soluble CD23 fragments endowed with proinflammatory effects. FASEB J. 2001;15:2027–9.
pubmed: 11511513
Rosales C. Neutrophil: A cell with many roles in inflammation or several cell types? Front Physiol. 2018;9:113.
pubmed: 29515456
pmcid: 5826082
Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: Pathophysiological consequences and underlying mechanisms. Clin Sci. 1998;94:461–71.